Log in
Registration
Українська
English
Search for:
Home
Electronic publication
Fresh number
Archives
Authors
About Edition
Subscription
Requirements for authors
Reviewing
Editorial board
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Contents of the journal : Т. 9, № 2 (34) 2019
Original Articles
Clinical case of dermatofibroma transformation in fibrosarcoma
Authors: Ostafiychuk V.V. Korovin S.I. Krotevych M.S. Kukushkina M.M.... Т. 9, № 2 (34) 2019
Combined effect of the vinorelbine with iron oxide nanoparticles and electromagnetic radiation on the Lewis lung carcinoma
Authors: Orel V.Е. Sivak L.A. Krotevych M.S. Dasiukevych O.Y.... Т. 9, № 2 (34) 2019
Role of TLR-2, TLR-4, TLR-9 gene polymorphism in prognosis of triple negative breast cancer
Authors: Lyalkin S. Sivak L.A. Khranovska N.M. Verovkina N.O. Т. 9, № 2 (34) 2019
Clinical and morphological characteristics in women with tumors of external genitals treated at National Cancer Institute
Authors: Samokhvalova O.O. Turchak O.V. Tkalya J. Т. 9, № 2 (34) 2019
The possibility of using the detection of sentinel lymph nodes after neoadjuvant polychemotherapy in patients with breast cancer
Authors: Smolanka I. Kostriba A.I. Chernysh V.O. Kuzmenko A.P.... Т. 9, № 2 (34) 2019
The results of stenting patients with upper-third and middle-third esophageal cancer
Authors: Kirkilevskyi S.I. Krahmalyov P.S. Frydel R.I. Т. 9, № 2 (34) 2019
Changing the Treatment Landscape of multiple myeloma (2003–2013). Own results
Authors: Novosad O. Kryachok I. Ulianchenko K.O. Skripets Т.V.... Т. 9, № 2 (34) 2019
The first experience of using dendritic cells immunotherapy in complex treatment of patients with glioblastoma in Ukraine
Authors: Khranovska N.M. Skachkova O.V. Gorbach O.I. Zhukova V.M.... Т. 9, № 2 (34) 2019
Predictive value of oxidative DNA damage biomarker (8-hydroxy-2’-deoxyguanosine) for the response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer
Authors: Zvirych V.V. Burlaka A.A. Kolesnik O.O. Michailovich Y.I. Т. 9, № 2 (34) 2019
Prediction of the effectiveness of neoadjuvant targeted therapy in patients with localized renal cell carcinoma
Author:Voylenko O. Т. 9, № 2 (34) 2019